Bioactive Composites for Bone Void Filler Compositions and Methods
Summary
The USPTO published patent application US20260108431A1 on April 23, 2026, covering bioactive composites for bone void filler compositions and methods for bone growth promotion. The application was filed on September 25, 2025, under Application No. 19339506, naming David Louis Kirschman, Dewey J. Weeda, and Shawn A. Hunter as inventors. The invention relates to a high-strength calcium acrylic modified polymer (CAMP) material designed for orthopedic and surgical applications requiring structural support and enhanced biological properties.
“This invention relates to bioactive composites, and more particularly, to bone void filler compositions including bioactive composites and/or implants and methods for the promotion of bone growth and regeneration.”
About this source
USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.
What changed
The USPTO published a patent application for bioactive composites designed for bone void filler compositions. The invention relates to calcium acrylic modified polymer (CAMP) materials intended for orthopedic and surgical applications, specifically addressing bone growth promotion and regeneration. CPC classifications include A61K 6/802, A61K 6/15, and A61K 6/838.\n\nMedical device manufacturers developing bone void fillers, orthopedic implants, or bioactive composite materials for surgical applications may wish to review this application for potential freedom-to-operate implications or licensing opportunities. Patent applicants and their competitors should monitor the prosecution of this application for claims that may affect existing product lines or development pipelines in the bone graft substitute space.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
BIOACTIVE COMPOSITES FOR BONE VOID FILLER COMPOSITIONS AND METHODS
Application US20260108431A1 Kind: A1 Apr 23, 2026
Inventors
David Louis Kirschman, Dewey J. Weeda, Shawn A. Hunter
Abstract
This invention relates to bioactive composites, and more particularly, to bone void filler compositions including bioactive composites and/or implants and methods for the promotion of bone growth and regeneration. This invention also relates to bone void fillers, specifically to a high-strength calcium acrylic modified polymer (CAMP) material designed for orthopedic and surgical applications requiring both structural support and enhanced biological properties.
CPC Classifications
A61K 6/802 A61K 6/15 A61K 6/838
Filing Date
2025-09-25
Application No.
19339506
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.